SQUAWK/NEWS
Account
Theme
Account
Menu
Live News NEWS FLASH L impact

Merck, Daiichi Sankyo Withdraw Application for Accelerated Approval of Lung Cancer Treatment

By Elias SchisgallMerck & Co. and Daiichi Sankyo have withdrawn their application seeking accelerated approval for a small cell lung cancer treatment, saying the data they had submitted to the Food and Drug Administration was insufficient.The two companies said they decided to withdraw the Biologic…

4568MRK

Related stories